Table 1 Expression differences and clinical features of ABCG2 and V-ATPase in pathological grading and TNM staging of esophageal squamous cell carcinoma

Male

253

14

25

14

54.72

u = 188.5.0 P = 0.007

12

31

10

77.36

u = 164.0 P = 0.001

Female

13

8

5

0

38.46

9

4

0

30.77

≤60

28

8

10

10

71.43

u = 408.0 P = 0.083

7

15

6

75.00

u = 439.0 P = 0.181

>60

38

14

20

4

63.16

14

20

4

63.16

I

15

13

0

2

13.33

${\bar{\chi }}^2=20.36$ P = 0.000

11

2

2

26.67

${\bar{\chi }}^2=11.89$ P = 0.003

α

24

6

17

1

75.00

6

17

1

75.00

β

27

3

13

11

88.89

4

16

7

85.19

Total

66

22

30

14

66.67

21

35

10

68.18

αa

27

18

9

0

33.33

${\bar{\chi }}^2=26.05$ P = 0.000

17

10

0

39.26

${\bar{\chi }}^2=22.68$ P = 0.000

αb

22

2

14

6

90.90

2

16

4

90.90

β

17

2

7

8

88.23

2

9

6

87.50

Total

66

22

29

14

66.67

21

35

10

68.18

Yes

39

5

20

14

87.18

u = 192.5 P = 0.000

5

24

10

87.18

u = 227.0 P = 0.000

No

27

17

10

0

37.04

16

11

0

40.74